Capital-Access Engagement
A Concentrated Path to Relevant Investor Conversations
PathFree Technologies has engaged Borex Capital to organize and facilitate three private New York investor presentation evenings. The engagement is designed to place Dr. Perry M. Brunette and PathFree’s flagship product, AiMediQ™ powered by datasyteAI™, directly before a targeted investor audience in an intimate, high-trust setting.
The Model
One company. One invited room. Three evenings.
PathFree Technologies has engaged Borex Capital under contract to organize a three-evening New York investor presentation and Q&A program conducted in private dinner settings.
Borex Capital’s private-dinner model is designed to place one presenting company before a targeted room of physicians, angel investors, family offices, venture investors, private-equity participants, and other prospective capital sources.
PathFree Technologies is the sole presenting company during the program.
Process
Invite. Present. Engage.
01
Invite
Borex Capital identifies, screens, and invites a targeted audience for each private evening.
02
Present
Dr. Perry M. Brunette personally presents PathFree Technologies, AiMediQ™ powered by datasyteAI™, and the investment opportunity.
03
Engage
Prospective investors ask questions, request information, and independently determine whether to proceed into follow-up and diligence.
Borex Capital serves as an organizer and investor-introduction facilitator. Borex Capital is not a guarantor of attendance, investor interest, diligence, commitments, or capital formation. Prospective investors make independent investment decisions.
Program Scale
Targeted invitations, not guaranteed rooms
- Private Presentation Evenings
- 03Private Presentation Evenings
- Targeted Invitations Per Evening
- 30Targeted Invitations Per Evening
- Targeted Invitations Across the Program
- 90Targeted Invitations Across the Program
Invitation figures are targets. Actual attendance, investor engagement, diligence activity, commitments, and investment outcomes may differ and are not guaranteed.
90 total invitations are contemplated across the three evenings, averaging 30 invitations per evening. Actual attendance may differ.
Borex Capital-Reported Network
The audience Borex Capital reports reaching
0+
Physicians
0+
Angel Investors
0+
Venture & Private Equity
0+
Family Offices
Network figures are reported by Borex Capital. They do not represent the number of people invited to, attending, or investing through the PathFree presentation evenings.
Sector Alignment
Where the room already looks
- Medtech
- Digital Health
- Life Sciences
- Software & AI
- Healthcare Technology
- Regulated Medical Systems
Why It Moves Faster
A More Concentrated Path to Investor Conversations
The Borex Capital format is designed to concentrate relevant investor introductions into three focused New York evenings. This may allow PathFree to establish meaningful investor conversations more efficiently than a fragmented outreach process.
Borex Capital facilitates introductions and follow-up but does not make investment decisions for prospective investors or guarantee that any person will invest.
Borex Capital serves as an organizer and investor-introduction facilitator. Borex Capital is not a guarantor of attendance, investor interest, diligence, commitments, or capital formation. Prospective investors make independent investment decisions.
Division of Responsibility
Who does what
Borex Capital
- Organizes and coordinates the private dinner settings
- Identifies and invites targeted prospective investors
- Facilitates introductions between PathFree and invitees
- Coordinates applicable event logistics
- Distributes PathFree-approved presentation materials
- Conducts appropriate post-event follow-up
- Supports the introduction process
PathFree Technologies
- Serves as the sole presenting company
- Provides all approved investor materials
- Presents the company and investment opportunity
- Presents AiMediQ™ powered by datasyteAI™
- Conducts the product discussion or walkthrough
- Answers investor questions
- Controls company, clinical, regulatory, product, and offering statements
- Conducts management follow-up and diligence
- Accepts or rejects investments under the definitive offering documents
Prospective Investors
- Attend voluntarily
- Review the information presented
- Ask questions and request additional materials
- Conduct their own diligence
- Consult their own advisers
- Make their own independent investment decisions
Next Step
Confidential materials are provided only after review.
Qualified prospective investors may request the PathFree Technologies information package and details of the New York investor presentation series.